ASCEND BY NTHRYS
Research Abroad Products

Epigenomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1–12 of 200 project topics
Multi-Omics Integration Platform for Biomarker Validation
A SaaS platform that integrates epigenomic, genomic, and transcriptomic data streams to identify and validate clinical biomarkers at scale. Enables pharma and diagnostic companies to accelerate drug development and companion diagnostic monetization through comprehensive molecular profiling.
Epigenomic Biomarker Discovery Service Platforms Click to view more details →
AI-Powered DNA Methylation Pattern Recognition Engine
Commercial software tool utilizing machine learning to detect novel methylation signatures associated with disease states and treatment response. Delivers subscription-based licensing revenue while reducing biomarker discovery timelines from years to months for clinical research organizations.
Epigenomic Biomarker Discovery Service Platforms Click to view more details →
Chromatin Accessibility SaaS for Cell State Classification
A cloud-based platform analyzing ATAC-seq and DNase-seq data to classify cellular states and predict epigenetic vulnerabilities in cancer cells. Provides recurring revenue through tiered subscriptions while enabling precision oncology companies to develop targeted therapeutic strategies.
Epigenomic Biomarker Discovery Service Platforms Click to view more details →
Histone Modification Profiling Workflow Automation Service
An enterprise software solution that automates ChIP-seq data processing and histone PTM interpretation for large-scale biomarker screening. Generates revenue through usage-based pricing while reducing manual analysis costs and improving throughput for research laboratories and biotech firms.
Epigenomic Biomarker Discovery Service Platforms Click to view more details →
Non-Invasive Circulating Epigenetic Biomarker Testing Platform
A commercial diagnostic service platform detecting cell-free DNA methylation and histone-modified nucleosomes in blood for early disease detection. Creates high-margin recurring revenue through clinical laboratory partnerships and direct-to-consumer testing while establishing proprietary biomarker intellectual property.
Epigenomic Biomarker Discovery Service Platforms Click to view more details →
Personalized Medicine Epigenomic Risk Stratification Software
A predictive analytics platform that combines epigenomic signatures with clinical data to stratify patient risk and treatment outcomes in real time. Monetizes through licensing to hospital networks and insurance providers while enabling precision medicine decision-making at point of care.
Epigenomic Biomarker Discovery Service Platforms Click to view more details →
Single-Cell Epigenomics Data Mining and Analytics Suite
An integrated bioinformatics platform designed to process scATAC-seq, scCUT&RUN, and single-cell bisulfite data with AI-driven pattern discovery. Delivers subscription revenue to academic and pharma customers while uncovering rare cell population biomarkers for immunotherapy development.
Epigenomic Biomarker Discovery Service Platforms Click to view more details →
Environmental Exposure Epigenetic Signature Detection Service
A SaaS-based service platform that identifies epigenetic markers of environmental toxin exposure, pollution, and occupational hazards in human populations. Generates revenue through corporate wellness programs, environmental agencies, and occupational health providers seeking validated exposure biomarkers.
Epigenomic Biomarker Discovery Service Platforms Click to view more details →
Longitudinal Epigenetic Clock Development and Licensing Platform
A proprietary software platform for creating tissue-specific and disease-specific epigenetic aging clocks from methylation data with clinical predictive power. Monetizes through biomarker licensing agreements, aging research partnerships, and integration into pharmaceutical clinical trial designs.
Epigenomic Biomarker Discovery Service Platforms Click to view more details →
Regulatory Element Activity Profiling and Target Discovery Tool
A commercial platform that maps disease-associated enhancers and silencers through H3K27ac and H3K27me3 profiling to identify druggable epigenetic targets. Delivers value through licensing to drug discovery teams and generating novel target intellectual property for therapeutic development pipelines.
Epigenomic Biomarker Discovery Service Platforms Click to view more details →
AI-Powered Histone Modification Screening Platform for Drug Discovery
A cloud-based SaaS platform that uses machine learning to identify novel histone modification targets and predict drug efficacy against epigenetic vulnerabilities. This solution accelerates therapeutic development timelines and reduces R&D costs by enabling high-throughput virtual screening of epigenetic biomarkers.
Epigenetic Drug Target Identification Platforms Click to view more details →
DNA Methylation Profiling Assay Kit for Precision Cancer Therapeutics
A standardized commercial assay kit that rapidly maps aberrant DNA methylation patterns to identify actionable epigenetic drug targets in tumor samples. This product generates recurring licensing revenue and enables pharmaceutical partners to stratify patient populations for targeted oncology programs.
Epigenetic Drug Target Identification Platforms Click to view more details →